Jean‐Pierre Marolleau

Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction

Philippe Menasché, Albert Hagège, Jean‐Thomas Vilquin et al. · Journal of the American College of Cardiology · 2003 · 1.1K citations

Medicine, Cardiology, Surgery +11

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study

Sylvie Castaigné, Cécile Pautas, Christine Terré et al. · The Lancet · 2012 · 995 citations

Medicine, Hematology, Pharmacology +10

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

Philippe Moreau, Michel Attal, Cyrille Hulin et al. · The Lancet · 2019 · 953 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With<i>NPM1</i>Mutation: A Study by the Acute Leukemia French Association Group

Marie Balsat, Aline Renneville, Xavier Thomas et al. · Journal of Clinical Oncology · 2017 · 292 citations

Medicine, Hematology, Oncology +16

Skeletal Myoblast Transplantation in Ischemic Heart Failure

Albert Hagège, Jean‐Pierre Marolleau, Jean‐Thomas Vilquin et al. · Circulation · 2006 · 275 citations · Full text

Medicine, Cardiology, Surgery +14